Skip to main content
DA

DeLorean Artificial Intelligence

DeLorean AI develops MARTI, a biologically validated medical AI platform that predicts disease onset and progression with 85-87% accuracy, enabling proactive healthcare interventions. By identifying high-risk patients and providing tailored care recommendations, MARTI helps insurers and care providers reduce medical costs by up to $100 per member per month while improving patient outcomes.

Palm Beach, AustraliaFounded 2019245K+ followers
Updated 20 months ago

Funding

$11M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

SC
Funding rounds are not available yet.

Founders

Product

Problem

Healthcare providers and insurers struggle with rising costs associated with chronic disease progression, often intervening only after significant health events occur. Identifying high-risk patients early and predicting disease trajectories remains a challenge, hindering proactive care management and preventative interventions. This reactive approach leads to increased hospitalizations, higher medical loss ratios, and poorer patient outcomes.

Solution

DeLorean AI offers MARTI, a medical AI platform designed to predict disease onset and progression, enabling proactive healthcare interventions. MARTI identifies high-risk patients before major health events occur, providing tailored care recommendations to prevent disease progression and reduce hospitalizations. By analyzing patient data, MARTI delivers insights that allow insurers and care providers to manage and mitigate significant health risks, improving patient outcomes while lowering medical costs. The platform's predictive capabilities facilitate dynamic risk stratification, transition prediction, and the identification of previously unknown patients at risk.

Target Audience

The primary target audience includes insurers and care providers seeking to prevent disease progression, reduce medical costs, and improve patient outcomes through proactive healthcare management.

Features

  • Predictive AI models that forecast disease onset and progression with 85-87% accuracy
  • Care modules focused on chronic illnesses including renal disease, diabetes, cardiovascular disease, behavioral health, and respiratory issues
  • Dynamic risk stratification to evaluate and update each patient’s current risk profile
  • Transition prediction to detect and alert healthcare providers to potential health status changes or significant medical events
  • Identification of unknown patients with undetected high-risk conditions
  • Tailored care recommendations aimed at preventing or mitigating the impact of predicted health events
This profile is AI-generated and may contain inaccuracies.